Zobrazeno 1 - 10
of 15
pro vyhledávání: '"O V, Brieieva"'
Autor:
N M Glushchenko, Miriam Mints, Vasyl F. Chekhun, N Yu Lukianova, L G Buchynska, Elena Kashuba, N P Iurchenko, O V Brieieva
Publikováno v:
Experimental Oncology. 40:303-308
Background: Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93613ec5273993591b720ee4801abbd
https://doi.org/10.31768/2312-8852.2018.40(4):303-308
https://doi.org/10.31768/2312-8852.2018.40(4):303-308
Publikováno v:
Experimental oncology. 42(4)
BACKGROUND Prognosis of the course of tumor progression is one of urgent problems of clinical oncology. A relevant specificity of endometrial cancer is its clinical polymorphism within the same histological type of the disease. The search for molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6cbc79749fb5011e9345f5d036d1aac
https://pubmed.ncbi.nlm.nih.gov/33355863
https://pubmed.ncbi.nlm.nih.gov/33355863
Publikováno v:
Experimental Oncology. 41
To analyze copy number variations of HER-2/neu, c-MYC and CCNE1 oncogenes and their protein expression in endometrioid endometrial carcinomas in relation to the degree of tumor progression and presence of a family history of cancer in cancer patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089282b27fb593414ec5ad7993711338
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.12973
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.12973
Autor:
L G, Buchynska, N P, Iurchenko, E V, Kashuba, O V, Brieieva, N M, Glushchenko, M, Mints, N Yu, Lukianova, V F, Chekhun
Publikováno v:
Experimental oncology. 40(4)
Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breast cancer (BC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a19c6a1a392fb916a6ada33d799dcd2e
https://pubmed.ncbi.nlm.nih.gov/30593750
https://pubmed.ncbi.nlm.nih.gov/30593750
Publikováno v:
Experimental Oncology. 37:272-276
Aim: To assess the expression of mismatch repair (MMR) proteins MSH2 and MLH1 and carry out microsatellite analysis in patients with endometrial cancer (EC) with regard to the family history of cancer. Materials and Methods: Morphological and immunoh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b913c01f4d391fd329bac750594d647
https://doi.org/10.31768/2312-8852.2015.37(4):272-276
https://doi.org/10.31768/2312-8852.2015.37(4):272-276
Autor:
L G, Buchynska, O V, Brieieva
Publikováno v:
Experimental oncology. 40(1)
The development of hormone-dependent cancers, including endometrial carcinomas, in great part may be mediated by the genotoxic effects of estrogen metabolites, among which 4-hydroxyestradiol (4OHE2) is characterized by the most prominent DNA-damaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::baa566e44c5ed2ca8f5aa43b86578430
https://pubmed.ncbi.nlm.nih.gov/29600983
https://pubmed.ncbi.nlm.nih.gov/29600983
Autor:
O V Brieieva, L G Buchynska
Background: The development of hormone-dependent cancers, including endometrial carcinomas, in great part may be mediated by the genotoxic effects of estrogen metabolites, among which 4-hydroxyestradiol (4OHE2) is characterized by the most prominent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e6c27cccf8a659221535b530fdfd9e
http://dspace.nbuv.gov.ua/handle/123456789/139243
http://dspace.nbuv.gov.ua/handle/123456789/139243
Publikováno v:
Experimental oncology. 39(4)
To date, genome instability is considered to be a common feature not only of tumor cells, but also of non-malignant cells of cancer patients, including peripheral blood lymphocytes (PBLs). The issue of the association between genome instability in tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a822a59d6358798347d96d427b8b6b8
https://pubmed.ncbi.nlm.nih.gov/29284781
https://pubmed.ncbi.nlm.nih.gov/29284781
To date, genome instability is considered to be a common feature not only of tumor cells, but also of non-malignant cells of cancer patients, including peripheral blood lymphocytes (PBLs). The issue of the association between genome instability in tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10109c70cde18d7a2b34e774abdc419
http://dspace.nbuv.gov.ua/handle/123456789/138546
http://dspace.nbuv.gov.ua/handle/123456789/138546